Methicillin-resistant Staphylococcus aureus in middle ear fluid of children

Joel Klein1, Shannon Chan

  • 1Division of Infectious Diseases, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA. jklein@nemours.org

Clinical Pediatrics
|July 25, 2009
PubMed
Abstract

Insights

Pediatric middle ear fluid samples show an increasing trend of Methicillin-resistant Staphylococcus aureus (MRSA) infections. Younger children under three years old are more susceptible to MRSA compared to methicillin-sensitive Staphylococcus aureus (MSSA).

Area of Science:

  • Pediatric infectious diseases
  • Otolaryngology
  • Microbiology

Background:

  • Pediatric infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) have seen a notable rise.
  • This increase prompted an investigation into MRSA's prevalence in pediatric middle ear fluid (MEF).

Purpose of the Study:

  • To evaluate the impact of increased MRSA infections on its isolation from pediatric MEF.
  • To determine the proportion of MRSA among Staphylococcus aureus isolates in children's middle ear infections.

Main Methods:

  • A retrospective analysis of electronic medical records from 2003-2007 at Alfred I. duPont Hospital for Children.
  • Examination of MEF isolates from children undergoing tympanostomy tube placement or with spontaneous ear drainage.
  • Identification and tabulation of all Staphylococcus aureus isolates from MEF.

Main Results:

  • Out of 920 MEF isolates reviewed, 121 cases involved Staphylococcus aureus.
  • In a cohort of 101 patients, 25 (24.7%) had MRSA, while 76 (75.3%) had methicillin-sensitive Staphylococcus aureus (MSSA).

Conclusions:

  • Younger children, specifically those under three years of age, were found to be more likely to have MRSA in their MEF.
  • The study highlights a significant presence of MRSA in pediatric middle ear infections, particularly in the youngest age group.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
52
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
121
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
180
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74